iOncologi, Inc. Acquires TargImmune Therapeutics to Expand and Strengthen Immunotherapy Pipeline Against Solid Tumors
Oncologi, Inc., a clinical-stage biopharmaceutical company focused on advancing immunotherapy platform technologies, today ...
Stifel Nicolaus Keeps Their Buy Rating on RegenXBio (RGNX)
Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on RegenXBio (RGNX – Research Report) today and set a price target of $40.00.
Tourmaline Bio (TRML) Gets a Buy from Wedbush
In a report released today, Laura Chico from Wedbush maintained a Buy rating on Tourmaline Bio (TRML – Research Report), with a price target of ...